Osimertinib Mesylate

Specifications

1421373-66-1CAS Number

806-779-0EC Number

N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acidIUPAC Name

C29H37N7O5SChemical Formula

595.7 g/molMolecular Weight

Osimertinib mesylate; 1421373-66-1; AZD-9291 mesylate; AZD9291 mesylate; Mereletinib mesylate; osimertinib mesilate; Mereletinib mesilate; RDL94R2A16; 2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-, methanesulfonate (1:1); CHEBI:90948; DTXSID101027822; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1); N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1); RefChem:58258; DTXCID601513393; AZD-9291 (Mesylate); Tagrisso; Osimertinib mesylate [USAN]; AZD 9291 mesylate; N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate; UNII-RDL94R2A16; N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid; MFCD28137994; Osimertinib mesilate (JAN); Osimertinib mesylate (USAN); OSIMERTINIB MESILATE [JAN]; Tagrisso (TN); 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1); AZD 9291 mesylate; Osimertinib mesylate; Osimertinib mesilate; osimertinib monomesylate; N-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid; osimertinib methanesulfonate; orb1303975; CHEMBL3545063; SCHEMBL14661152; SCHEMBL29353024; SCHEMBL29375936; C29H37N7O5S; OSIMERTINIB MESYLATE [MI]; FUKSNUHSJBTCFJ-UHFFFAOYSA-N; HMS5084M21; HY-15772AR; Osimertinib (mesylate) (Standard); EX-A1577; EBC-17161; HY-15772A; OSIMERTINIB MESILATE [WHO-DD]; AKOS026673944; DS-9913; SB22953; AC-29022; DA-35303; FD146297; OSIMERTINIB MESYLATE [ORANGE BOOK]; S5078; AZD-9291 mesylate (OsimertinibMereletinib)?; D10766; Q27162942; AZD9291 Ms salt, Osimertinib Ms salt; Mereletinib Ms salt; N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide methanesulfonate; N-.(2-.((2-.(Dimethylamino) ethyl) (methyl) amino) - 4- methoxy- 5- ((4- (1- methyl- 1H- indol- 3- yl) pyrimidin- 2- yl) amino) phen yl) acrylamide methanesulfonate; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonateSynonyms